Zobrazeno 1 - 10
of 18
pro vyhledávání: ''
Publikováno v:
Breast Disease. 40:63-68
BACKGROUND: Accumulating evidence highlights that long noncoding RNA (lncRNA) DSCAM-AS1 play a key regulatory role in different stages of cancer development and progression. This study aimed to investigate whether the expression of DSCAM-AS1 is dereg
Publikováno v:
Cancer Biomarkers. 26:203-207
OBJECTIVE To investigate the diagnostic and prognostic values of long non-coding RNA H19 (H19) in patients with papillary thyroid carcinoma (PTC). METHODS This retrospective, nonrandomised study included 410 patients with PTC and 89 patients with ben
Autor:
Jianyue Huang, Jiyang Fang
Publikováno v:
Cancer Biomarkers. 24:509-513
Glioma is the most common primary malignant tumor in the nervous system.To investigate the expression of long non-coding RNA Pvt1 oncogene (PVT1) in glioma and its clinical significance.The expression levels of PVT1 were determined in 59 glioma and 1
Autor:
Rong Xie, Shuyong Zhang, Zhi Wang, Chengfeng Xiong, Meijun Zhong, Wanzhi Chen, Tao Zhou, Yunxia Lv, Jichun Yu
Publikováno v:
Cancer Biomarkers. 23:185-191
BACKGROUND Long non-coding RNAs (lncRNAs) were recently identified as crucial regulators of papillary thyroid cancer (PTC). However, the clinical role and regulatory functions of lncRNA cancer susceptibility candidate 2 (CASC2) in PTC remain unknown.
Publikováno v:
Cancer Biomarkers. 23:221-225
Background Gastric cancer (GC) is the third leading cause of cancer-related death in the world. Dysfunction of long noncoding RNAs (lncRNAs) in cancers, especially those with role in pluripotency, are approved by increasing evidence. Objective SOX2 o
Publikováno v:
Cancer Biomarkers. 22:781-785
BACKGROUND Long noncoding RNA ultraconserved element 338 (uc.338) is a long non-coding RNA reported to function as a promoter in non-small cell lung cancer (NSCLC). However, the function and potential mechanism of uc.338 in NSCLC is still unclear. OB
Publikováno v:
Cancer Biomarkers. 20:511-519
Background Long noncoding RNAs (lncRNA) have been verified to be involved in hepatocellular carcinoma (HCC) progression. However, the potential biologic function of PVT1 in HCC is not still fully known. Methods PVT1 and miR-214 were detected by qRT-P
Publikováno v:
Cancer Biomarkers. 20:67-73
Background Colorectal carcinoma (CRC) is the vital cancer mortality worldwide and the long noncoding RNAs (lncRNAs) is considered as an important biomarker. The aim of this study was to examine the influence of lncRNA-SNHG1in CRC, and explore the rel
Publikováno v:
Cancer Biomarkers. 18:285-290
BACKGROUND Hepatocellular carcinoma (HCC), is an extremely aggressive malignancy with poor prognosis and high fatality rates worldwide. Accumulating evidence indicated that novel biomarkers are required to get a better understanding of the biological
Autor:
Mei-Xia Zhang, Zhi-Xiong Long, Ximing Xu, Yuan-Yuan Gan, Na-Na Han, Yongfa Zheng, Wei Ge, Jun-Jian Deng, Xiaoqin He, Yujie Zhou, Huiling Liang, Jia-Jun Yu
Publikováno v:
Tumor Biology, Vol 39 (2017)
Long non-coding RNAs have previously been demonstrated to play important roles in regulating human diseases, especially cancer. However, the biological functions and molecular mechanisms of long non-coding RNAs in hepatocellular carcinoma have not be